NHS to provide ruxolitinib cream for nearly 100,000 vitiligo patients

KEY INFORMATION:

• The NHS is offering ruxolitinib, the first approved cream to restore skin colour for people with non-segmental vitiligo.
• Nearly 100,000 people aged 12 and over are eligible for the treatment.
• The cream is applied twice daily, with clinical trials showing at least 75% re-pigmentation in many facial cases.
• Treatment is available where standard steroid creams have proven ineffective or unsuitable.
• Vitiligo affects approximately 1 in 100 people in the UK and is an autoimmune condition.

Tens of thousands of people living with vitiligo affecting the face are to be offered the first approved medicine on the NHS designed to restore lost skin colour.

The treatment, a cream known as ruxolitinib, will be available to approximately 100,000 people aged 12 and over who have non-segmental vitiligo.

This medical breakthrough follows a deal struck by the NHS to provide a dedicated re-pigmentation therapy. The treatment offers a profound shift in care for those with the autoimmune condition, moving beyond traditional methods that merely camouflage white patches or rely on long-term steroid use.

Restoring pigment and confidence

Vitiligo is a condition where the immune system mistakenly attacks melanocytes—the cells responsible for skin pigment. While not physically painful, the emotional distress and impact on mental health can be significant, particularly when the condition affects visible areas like the face and hands.

Ruxolitinib works by calming the immune response at the application site, allowing skin tone to return gradually. Clinical trials have demonstrated that twice-daily application can result in at least a 75% return of skin colour for many patients, with progress typically assessed after six months of use.

Professor Meghana Pandit, National Medical Director at NHS England, said: “For the first time, we now have an approved treatment available on the NHS that can significantly restore skin colour rather than simply covering the condition up. While it won’t be right for everyone, for some people this could make a profound difference to how they feel about themselves.”

A new era for dermatological care

The approval of this cream marks a fundamental change in the equitable care of vitiligo patients. Previous options were often limited to hospital-based light therapy or steroid creams that could thin and damage the skin over time. This new targeted approach provides a more sustainable home-based option.

Abigail Hurrell, CEO of The Vitiligo Society, said: “Today’s approval of ruxolitinib represents a historic milestone and the first time the NHS has recognised and funded a dedicated re-pigmentation treatment. This decision acknowledges the significant psychological, social and medical impact of vitiligo.”

Accessing the treatment

The cream will be offered to eligible patients where standard steroid treatments have not worked or are deemed unsuitable. While side effects are generally mild, such as slight irritation or redness at the application site, patients are advised to consult with their GP or dermatologist to determine if the treatment is appropriate for their specific case.

OFFICIAL SOURCE VERIFICATION: This report is based on official data from Council / Local Authority. Document: Tens of thousands with vitiligo to be offered “life-changing” new cream on NHS to restore skin colour Source Link: https://www.england.nhs.uk/2026/02/tens-thousands-vitiligo-offered-life-changing-new-cream-restore-skin-colour/

Related Links:

MORE: New auction powers to fill long-term empty shops on Lambeth high streets — https://trendwiremedia.com/2026/02/07/new-auction-powers-to-fill-long-term-empty-shops-on-lambeth-high-streets/

MORE: New crackdown as illegal dumping costs taxpayers £500,000 — https://trendwiremedia.com/2026/02/06/new-crackdown-as-illegal-dumping-costs-taxpayers-500000/

MORE: Thousands of new jobs secured for Londoners — https://trendwiremedia.com/2026/02/09/thousands-of-new-jobs-secured-for-londoners/